Chang Sun to Solubility
This is a "connection" page, showing publications Chang Sun has written about Solubility.
Connection Strength
5.627
-
Mechanism for the Reduced Dissolution of Ritonavir Tablets by Sodium Lauryl Sulfate. J Pharm Sci. 2019 Jan; 108(1):516-524.
Score: 0.641
-
Modulating Pharmaceutical Properties of Berberine Chloride through Cocrystallization with Benzendiol Isomers. Pharm Res. 2023 Dec; 40(12):2791-2800.
Score: 0.220
-
Profound effects of gastric secretion rate variations on the precipitation of erlotinib in duodenum - An in vitro investigation. Int J Pharm. 2022 May 10; 619:121722.
Score: 0.203
-
Complexation with aromatic carboxylic acids expands the solid-state landscape of berberine. Int J Pharm. 2022 Apr 05; 617:121587.
Score: 0.201
-
Simultaneous improvement of physical stability, dissolution, bioavailability, and antithrombus efficacy of Aspirin and Ligustrazine through cocrystallization. Int J Pharm. 2022 Mar 25; 616:121541.
Score: 0.201
-
Formulation strategies for mitigating dissolution reduction of p-aminobenzoic acid by sodium lauryl sulfate through diffusion layer modulation. Int J Pharm. 2022 Jan 05; 611:121310.
Score: 0.198
-
Pharmaceutical Lauryl Sulfate Salts: Prevalence, Formation Rules, and Formulation Implications. Mol Pharm. 2022 02 07; 19(2):432-439.
Score: 0.197
-
Efficient development of sorafenib tablets with improved oral bioavailability enabled by coprecipitated amorphous solid dispersion. Int J Pharm. 2021 Dec 15; 610:121216.
Score: 0.197
-
Novel Salt-Cocrystals of Berberine Hydrochloride with Aliphatic Dicarboxylic Acids: Odd-Even Alternation in Physicochemical Properties. Mol Pharm. 2021 04 05; 18(4):1758-1767.
Score: 0.189
-
Development of piroxicam mini-tablets enabled by spherical cocrystallization. Int J Pharm. 2020 Nov 30; 590:119953.
Score: 0.183
-
The efficient development of a sildenafil orally disintegrating tablet using a material sparing and expedited approach. Int J Pharm. 2020 Nov 15; 589:119816.
Score: 0.182
-
Material-Sparing and Expedited Development of a Tablet Formulation of Carbamazepine Glutaric Acid Cocrystal- a QbD Approach. Pharm Res. 2020 Jul 23; 37(8):153.
Score: 0.181
-
A microcrystalline cellulose based drug-composite formulation strategy for developing low dose drug tablets. Int J Pharm. 2020 Jul 30; 585:119517.
Score: 0.179
-
Simultaneous taste-masking and oral bioavailability enhancement of Ligustrazine by forming sweet salts. Int J Pharm. 2020 Mar 15; 577:119089.
Score: 0.175
-
A systematic evaluation of poloxamers as tablet lubricants. Int J Pharm. 2020 Feb 25; 576:118994.
Score: 0.174
-
Crystallographic and Energetic Insights into Reduced Dissolution and Physical Stability of a Drug-Surfactant Salt: The Case of Norfloxacin Lauryl Sulfate. Mol Pharm. 2020 02 03; 17(2):579-587.
Score: 0.174
-
Microstructures and pharmaceutical properties of ferulic acid agglomerates prepared by different spherical crystallization methods. Int J Pharm. 2020 Jan 25; 574:118914.
Score: 0.173
-
Expedited Tablet Formulation Development of a Highly Soluble Carbamazepine Cocrystal Enabled by Precipitation Inhibition in Diffusion Layer. Pharm Res. 2019 Apr 23; 36(6):90.
Score: 0.166
-
Improving solid-state properties of berberine chloride through forming a salt cocrystal with citric acid. Int J Pharm. 2019 Jan 10; 554:14-20.
Score: 0.160
-
Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer. Pharm Res. 2017 12 29; 35(1):4.
Score: 0.151
-
Expedited Development of Diphenhydramine Orally Disintegrating Tablet through Integrated Crystal and Particle Engineering. Mol Pharm. 2017 10 02; 14(10):3399-3408.
Score: 0.148
-
Expedited development of a high dose orally disintegrating metformin tablet enabled by sweet salt formation with acesulfame. Int J Pharm. 2017 Oct 30; 532(1):435-443.
Score: 0.148
-
Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression. J Pharm Sci. 2017 07; 106(7):1772-1777.
Score: 0.143
-
Mechanical Properties and Tableting Behavior of Amorphous Solid Dispersions. J Pharm Sci. 2017 01; 106(1):217-223.
Score: 0.139
-
The development of carbamazepine-succinic acid cocrystal tablet formulations with improved in vitro and in vivo performance. Drug Dev Ind Pharm. 2016; 42(6):969-76.
Score: 0.130
-
Validation and applications of an expedited tablet friability method. Int J Pharm. 2015 Apr 30; 484(1-2):146-55.
Score: 0.124
-
Cocrystallization for successful drug delivery. Expert Opin Drug Deliv. 2013 Feb; 10(2):201-13.
Score: 0.107
-
Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide. Pharm Res. 2012 Jul; 29(7):1854-65.
Score: 0.101
-
Solid-state properties and crystallization behavior of PHA-739521 polymorphs. Int J Pharm. 2006 Aug 17; 319(1-2):114-20.
Score: 0.067
-
Development of direct compression Acetazolamide tablet with improved bioavailability in healthy human volunteers enabled by cocrystallization with p-Aminobenzoic acid. Int J Pharm. 2024 Mar 05; 652:123793.
Score: 0.057
-
Harmonizing Biopredictive Methodologies Through the Product Quality Research Institute (PQRI) Part I: Biopredictive Dissolution of Ibuprofen and Dipyridamole Tablets. AAPS J. 2023 04 21; 25(3):45.
Score: 0.055
-
A Rheological Approach for Predicting Physical Stability of Amorphous Solid Dispersions. J Pharm Sci. 2023 01; 112(1):204-212.
Score: 0.052
-
The impact of solid-state form, water content and surface area of magnesium stearate on lubrication efficiency, tabletability, and dissolution. Pharm Dev Technol. 2021 Feb; 26(2):150-156.
Score: 0.046
-
Polymer Nanocoating of Amorphous Drugs for Improving Stability, Dissolution, Powder Flow, and Tabletability: The Case of Chitosan-Coated Indomethacin. Mol Pharm. 2019 03 04; 16(3):1305-1311.
Score: 0.041
-
Dapagliflozin-citric acid cocrystal showing better solid state properties than dapagliflozin. Eur J Pharm Sci. 2017 Jun 15; 104:255-261.
Score: 0.036
-
Resveratrol cocrystals with enhanced solubility and tabletability. Int J Pharm. 2016 Jul 25; 509(1-2):391-399.
Score: 0.034
-
Designing micellar nanocarriers with improved drug loading and stability based on solubility parameter. Mol Pharm. 2015 Mar 02; 12(3):816-25.
Score: 0.031
-
Characterization of thermal behavior of deep eutectic solvents and their potential as drug solubilization vehicles. Int J Pharm. 2009 Aug 13; 378(1-2):136-9.
Score: 0.021